ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 113

$480K Total Retail Price of All Prescriptions

Rank: 35 out of 113

487 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,062 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 519 435 1 1
SIMVASTATIN 342 303 2 2
LISINOPRIL 320 262 3 3
OMEPRAZOLE 238 201 4 5
HYDROCODONE-ACETAMINOPHEN 233 180 S3 5 7
AMLODIPINE BESYLATE 213 195 6 4
POTASSIUM CHLORIDE 206 183 7 12
FUROSEMIDE 201 167 8 6
CITALOPRAM HBR 171 139 9 17
METOPROLOL SUCCINATE 167 147 10 10
WARFARIN SODIUM 165 147 11 8
HYDROCHLOROTHIAZIDE 151 139 12 9
METFORMIN HCL ER 147 99 13 51
LOSARTAN POTASSIUM 131 117 14 13
FLUOXETINE HCL 125 97 15 31
ZOLPIDEM TARTRATE 125 108 15 19
GABAPENTIN 97 83 17 18
TRIAMTERENE-HCTZ 94 84 18 26
ALLOPURINOL 91 67 19 20
ALENDRONATE SODIUM 91 89 19 22
TRAZODONE HCL 90 69 21 41
PRAVASTATIN SODIUM 87 64 22 23
NEXIUM 85 46 23 47
DIOVAN 82 82 24 42
DIGOXIN 82 75 24 27
ATENOLOL 79 75 26 16
TRAMADOL HCL 79 57 26 29
METOPROLOL TARTRATE 78 70 28 14
PAROXETINE HCL 75 70 29 45
ATORVASTATIN CALCIUM 68 62 30 15
SERTRALINE HCL 66 23 31 21
FLUTICASONE PROPIONATE 66 65 31 39
MELOXICAM 64 60 33 44
DONEPEZIL HCL 63 63 34 33
IRBESARTAN 59 46 35 99
VENLAFAXINE HCL ER 57 52 36 55
ADVAIR DISKUS 56 56 37 35
GLIPIZIDE ER 56 56 37 97
AMITRIPTYLINE HCL 52 42 R 39 58
OXYBUTYNIN CHLORIDE 52 48 39 89
PREMARIN 51 48 R 41 69
LYRICA 51 43 41 83
BENICAR 50 38 43 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.